Science Creates: deep tech ecosystem (Bristol-based, founded 2015) combining incubation + venture capital + national programmes. SCVC (VC arm): 19 investments, 3 funds, founded 2020. Key portfolio: CellVoyant (stem cells/AI), Forefront RF (connectivity), Scarlet Therapeutics (red blood cell therapeutics), Portal Biotech. Team: ~5-7 professionals (exited founders, PhD scientists). Infrastructure: OMX (30k sqft labs, March 2026), 2 prior incubators. Founder Dr. Harry Destecroix MBE (2025). Value: hands-on support, lab access, £8.5m facilities investment.
Investment Focus
Investment Thesis
Early-stage deep tech from Bristol & Bath university spinouts. Focus: quantum, engineering biology, advanced materials, climate tech, health innovation, AI-biotech intersect. Seed-Series A. Check £100k-£1m. Board seats + mentorship. Integrated ecosystem: 3 incubators (75k sqft), accelerators (engineering biology UKRI-backed), network advisors. Avoid: non-academic founders, late-stage capital plays. Founded 2015 post-exit Ziylo (Novo Nordisk $800m). Est. 100+ portfolio cos.
Interested in connecting?
Visit their website or reach out directly.